EXECUTIVE SUMMARY In the last two decades, technology has drastically changed how we conduct business and lead our personal lives. However, medicine and more specifically the business of clinical trials hasn’t kept up. Finding patients for clinical trials, or patient recruitment, is still conducted very much as it was 20 years ago with very little having changed. It’s no surprise that enrolling a sufficient number of patients in trials remains a chief bottleneck in the drug development process, attributing to delays of up to six months or more in 45% of studies. Relying on manual chart review of patient records to identify eligibl... More »
When sponsor companies require clinical trial sites to source commercial drugs and ancillary supplies independently, it can impact the outcome of clinical trials. Sites often lack the expertise, time, resources and processes for efficient and effective supply chain management. It is critical that sponsors evaluate these challenges and optimize their sourcing strategies to minimize risk and maximize success. More »
Learn how Clinical Conductor CTMS helps research organizations maintain compliance and improve their research methods. More »
The terms and processes by which investigative sites are paid to conduct clinical trials have long been a thorny issue. These issues have impacted clinical research sites’ ability to focus on conducting quality research and meet enrollment goals — as well as continue their role as the bridge from promise to reality for new therapeutic treatments. More »
